The effects of TNF blockade (using etanercept) on substrates of mood and cognition in patients with inflammatory arthritis.
Phase of Trial: Phase II
Latest Information Update: 15 Jun 2016
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriatic arthritis
- Focus Adverse reactions
- Acronyms SPECT
- 08 Oct 2014 Accrual to date is 86% according to United Kingdom Clinical Research Network record
- 08 Oct 2014 Status changed from recruiting to completed as reported by United Kingdom Clinical Research Network .
- 21 Jun 2012 United Kingdom Clinical Research Network reports accrual to date changed from 83% to 86%.